SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-028871
Filing Date
2023-08-10
Accepted
2023-08-10 16:19:57
Documents
3
Period of Report
2023-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691698785.html 4  
1 FORM 4 wk-form4_1691698785.xml 4 3257
2 EX-24 powerofattorney_sandlerx.htm EX-24 3784
3 GRAPHIC powerofattorney_sandlerx001.jpg GRAPHIC 202079
  Complete submission text file 0001628280-23-028871.txt   286849
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR PUDONG SHANGHAI F4 201210
Business Address
Sandler Alan B. (Reporting) CIK: 0001835966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 231159799